Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Obesity and Diabetes Therapy
Research from Nihon University has provided new data on obesity and diabetes therapy
December 10th, 2007
A new study, 'Combination therapy of pioglitazone with voglibose improves glycemic control safely and rapidly in Japanese type 2-diabetic patients on hemodialysis,' is now available. According to a study from Tokyo, Japan, "Unfortunately, clinicians are diagnosing a growing number of patients on hemodialysis (HD) with insulin-resistant, Type 2 diabetes in Japan. While alpha-glucosidase inhibitors (alpha-GI) such as oral antidiabetic agents are indicated for Japanese diabetics on HD, pioglitazone and other PPARgamma agonists are now contraindicated." "No prospective study has evaluated the use of thiazolidinediones in diabetics with end-stage renal disease (ESRD) in...
Source: Obesity & Diabetes Week (2007-12-10)
|
